Dr. Burnett’s research focuses on the relationship between EGFR and AKT signal transduction pathways, energy metabolism and NADPH oxidase (NOX)-induced oxidative stress in cancer cells to develop highly targeted strategies to improve cancer patient treatment and outcomes.
Cancer biology, mechanisms of resistance to EGFR/Akt inhibitors, NOX signaling pathways, oxidative stress, redox regulation of IL-6 and energy metabolism.